Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients
Author(s) -
Frederik A. Verburg,
Uwe Mäder,
Karina Tanase,
E. Thies,
Stefanie Dießl,
Andreas K. Buck,
Markus Luster,
Christoph Reiners
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2458
Subject(s) - medicine , life expectancy , lymph node , stage (stratigraphy) , population , thyroid cancer , cancer , thyroidectomy , thyroid carcinoma , relative survival , confidence interval , survival rate , thyroid , oncology , urology , surgery , cancer registry , paleontology , environmental health , biology
Differentiated thyroid carcinoma (DTC) generally has a good prognosis. As yet, however, it is unclear whether life expectancy is reduced in these patients and, if so, to what extent. The aim of this study was to determine how the all-cause mortality rate in DTC patients compares to that of the general population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom